Title : Immunologic analysis of a phase I/II study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-positive tumors.

Pub. Date : 2004 Mar-Apr

PMID : 14770084






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ninety-six percent (23/24) of the patients vaccinated with MAGE-3 protein in AS02B adjuvant elicited a significant anti-MAGE-3 IgG antibody response after 4 vaccinations, and all developed anti-ProtD IgG antibodies. as02b adjuvant MAGE family member A3 Homo sapiens
2 Ninety-six percent (23/24) of the patients vaccinated with MAGE-3 protein in AS02B adjuvant elicited a significant anti-MAGE-3 IgG antibody response after 4 vaccinations, and all developed anti-ProtD IgG antibodies. as02b adjuvant MAGE family member A3 Homo sapiens